1. Tuberculosis vaccine trial gets underway;Bosch;Lancet Infect Dis,2004
2. Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial;Vuola;AIDS,2003
3. Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccine for the prevention of HIV associated tuberculosis;Waddell;Clin Infect Dis,2000
4. Vuola J, Cole B, Matee M, et al. Baseline mycobacterial immunity in HIV-positive adults entering the DARDAR TB booster vaccine trial in Tanzania. 42nd annual meeting of the Infectious Disease Society of America; 2004; Boston, MA. Abstract 882.
5. Ibanga HB, Hill PC, Owiafe PK, McShane H, Hill AV, Brookes R. Screening, safety and immunogenicity of modified vaccinia virus Ankara vaccine against tuberculosis in Africa: results from the Gambia. 42nd annual meeting of the Infectious Disease Society of America; 2004; Boston, MA. Abstract 588.